This study is in progress, not accepting new patients
The REPLACE Registry for Cholbam® (Cholic Acid)
Summary
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Travere Therapeutics, Inc.
- ID
- NCT03115086
- Study Type
- Observational [Patient Registry]
- Participants
- Expecting 55 study participants
- Last Updated